Stockscreener 앱 받기
72.92
0.48%
-0.34
전일 마감가:
$73.26
열려 있는:
$73.15
하루 거래량:
570.83K
Relative Volume:
0.38
시가총액:
$9.95B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
72.92
EPS:
1
순현금흐름:
$232.07M
1주 성능:
-2.95%
1개월 성능:
+5.14%
6개월 성능:
+42.28%
1년 성능:
+66.34%
1일 변동 폭
$72.33
$73.57
1주일 범위
$69.16
$75.44
52주 변동 폭
$40.87
$85.21
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
72.92 | 13.72B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
301.00 | 48.56B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
93.12 | 15.92B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
88.12 | 7.63B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.30 | 7.38B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
How Doximity Inc. Class stock reacts to weak economy2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
News impact scoring models applied to Doximity Inc.Trade Performance Summary & Risk Controlled Swing Alerts - newser.com
Is Doximity Inc. Class stock a safe buy pre earningsJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com
BofA Securities maintains Neutral rating on Doximity stock amid FDA ad crackdown - Investing.com
Doximity Inc. stock momentum explainedTrade Volume Summary & Stock Market Timing Techniques - newser.com
Is Doximity Inc. forming a reversal pattern2025 Market Trends & Technical Buy Zone Confirmation - newser.com
What catalysts could drive Doximity Inc. stock higher2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Doximity, Inc. $DOCS Shares Acquired by Robeco Institutional Asset Management B.V. - MarketBeat
Wealth Enhancement Advisory Services LLC Lowers Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Why Doximity Inc. Class stock appears on watchlistsJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - newser.com
How Investors May Respond To Doximity (DOCS) Integrating Pathway AI and Launching Free Clinical Scribe - Yahoo Finance
Fairvoy Private Wealth LLC Acquires 5,436 Shares of Doximity, Inc. $DOCS - MarketBeat
Lecap Asset Management Ltd. Sells 36,278 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity stock maintains Outperform rating at Raymond James on digital marketing trends - Investing.com
Doximity stock price target maintained at $75 by BofA on Alnylam ad shift - Investing.com
Will Doximity Inc. Class stock announce a stock splitPortfolio Performance Report & Daily Volume Surge Signals - newser.com
Synergy Asset Management LLC Invests $18.54 Million in Doximity, Inc. $DOCS - MarketBeat
Using flow based indicators on Doximity Inc.Exit Point & Stepwise Trade Signal Guides - newser.com
Using data tools to time your Doximity Inc. exitQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Doximity Inc. Class stock beat growth indexes2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
Doximity Inc. stock trendline breakdownWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Doximity surges as Q2 beat draws upgrades - MSN
Can Doximity's New AI Suite Drive the Growth It Needs? - sharewise.com
Doximity (NASDAQ:DOCS) Downgraded by The Goldman Sachs Group to Strong Sell - MarketBeat
Doximity (DOCS) Stock Sinks As Market Gains: What You Should Know - sharewise.com
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - Business Wire
Why Doximity (DOCS) Stock Is Down Today - TradingView
Doximity (DOCS) Analyst Downgrade by Goldman Sachs Raises Price Target | DOCS Stock News - GuruFocus
Doximity CEO Jeffrey Tangney sells $75.7 million in stock - MSN
Doximity, Inc. (DOCS) Acquires Pathway Medical to Supercharge AI Clinical Tools - MSN
Doximity (NASDAQ:DOCS) Shares Gap DownTime to Sell? - MarketBeat
Goldman Sachs Downgrades Doximity to Sell From Neutral, Adjusts Price Target to $64 From $57 - MarketScreener
Doximity raises FY2025 revenue guidance by $28M amid strong Q3 performance - MSN
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.75%
0.78%
자본화:
|
볼륨(24시간):